Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-06-26
2007-06-26
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S190100, C424S192100, C424S193100, C424S197110, C424S203100, C424S249100, C424S250100, C424S256100, C530S300000, C530S350000
Reexamination Certificate
active
10841324
ABSTRACT:
The present invention is concerned with a fragment of IgA1-protease having 40 to 200 amino acid residues and comprising at least 40 amino acids of an amino acid sequence as shown in SEQ ID NO:1, beginning with the amino acid in any one of positions 1 to 5 and ending with an amino acid in any one of positions 40 to 104 or a homologous sequence, its use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide.
REFERENCES:
patent: 5268270 (1993-12-01), Meyer et al.
patent: 0 254 090 (1988-01-01), None
patent: 0 326 111 (1989-08-01), None
patent: 0 429 816 (1991-06-01), None
patent: WO 90/11367 (1990-10-01), None
Poulsen et al. 1989, Infect. Immun., 57(10): 3097-3105.
Pohlner et al., 1987, Nature, 325: 458-462.
International Search Report dated Jul. 23, 2998.
Lomholt, Hans,Molecular Microbiology15(3): 495-506, 1995.
Siber, G.R.,Science265: 1385-1387, 1994.
Romero, J.D. et al.,Clinical Microbiology Reviews7(4): 559-575, 1994.
Lomholt, H.,APMIS104:5-28, 1996.
Achtman Mark
Moreau Monique
Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
Morgan & Lewis & Bockius, LLP
Navarro Mark
Pasteur Merieux Serums et Vaccins S.A.
LandOfFree
IgA1 protease fragment as carrier peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IgA1 protease fragment as carrier peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IgA1 protease fragment as carrier peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3885307